 |
市场调查报告书
商品编码
1898525
微流体免疫检测市场规模、份额和成长分析（按产品、技术、应用、最终用户和地区划分）－2026-2033年产业预测Microfluidic Immunoassay Market Size, Share, and Growth Analysis, By Product (Consumables, Cartridges), By Technology (Electrochemical Detection, Optical Detection), By Application, By End User, By Region - Industry Forecast 2026-2033 |
||||||
全球微流体免疫检测市场规模预计在 2024 年达到 12.9 亿美元，从 2025 年的 13.9 亿美元成长到 2033 年的 25.4 亿美元，在预测期（2026-2033 年）内复合年增长率为 7.8%。
微流体免疫检测市场正经历显着成长，其主要驱动力是资源匮乏地区改善患者照护的需求。人口结构变化以及对经济高效、高通量诊断解决方案日益增长的需求，正推动照护现场（POC）在医院、诊所和家庭中的广泛应用。儘管目前的POC设备仍面临一些挑战，例如需要检体预处理和结果不稳定，但微型化的晶片实验室（LOC）系统已成为主流。这些系统具有试剂消费量少、结果更快更准确等优点。推动市场扩张的因素包括：微流体技术研究的不断深入、创业投资投资对基于LOC的诊断技术的投资不断增长、急诊护理中对快速决策的需求，以及老龄化社会中慢性病患病率的上升。
推动全球微流体免疫检测市场发展的因素
受多种因素驱动，尤其是在新兴经济体，全球微流体免疫检测市场预计将迎来显着成长。纸基微流体技术等创新技术进一步拓展了市场机会。人口老化以及大量感染疾病和非传染性疾病患者也推动了这一增长。此外，研发投入的增加、对高品质医疗服务需求的成长、可支配收入的提高以及医疗基础设施的进步，都为微流体免疫检测市场的发展创造了有利环境。
全球微流体免疫检测市场面临的限制因素
全球微流体免疫检测市场面临许多可能阻碍其成长的重大挑战。其中一项主要挑战是选择合适的基底材料，这对于微流体晶片的製造至关重要。此外，复杂的健保报销流程也为製造商带来挑战。扩大生产规模以满足大众市场需求同样是一大障碍，开发价格适中、能够满足经济发展中地区需求的产品也至关重要。解决这些限制因素对于充分发挥这项创新市场的潜力并使其惠及更多用户至关重要。
全球微流体免疫检测市场趋势
全球微流体免疫检测市场正经历显着的成长趋势，这主要得益于晶片实验室（LOC）技术的日益普及。 LOC技术将复杂的实验室流程整合到小型设备中，不仅提高了便携性，还减少了对传统大规模设备的依赖。特别是纸基微流体控装置，因其成本效益和多功能性，尤其在开发中国家的即时侦测（POC）应用中备受关注。纸基微流控装置无需外力即可透过毛细作用移动流体，因此在学术界和商业领域都得到了广泛的研究，使其成为各种医疗诊断应用的实用解决方案，并有助于改善医疗保健服务的可及性。
目录
介绍
- 调查目标
- 调查范围
- 定义
调查方法
- 资讯收集
- 二手资料和一手资料方法
- 市场规模预测
- 市场假设与限制
执行摘要
- 全球市场展望
- 供需趋势分析
- 细分市场机会分析
市场动态与展望
- 市场规模
- 市场动态
- 驱动因素和机会
- 限制与挑战
- 波特分析
关键市场考察
- 关键成功因素
- 竞争程度
- 关键投资机会
- 市场生态系统
- 市场吸引力指数（2025）
- PESTEL 分析
- 总体经济指标
- 价值链分析
- 定价分析
- 案例研究分析
全球微流体免疫检测市场规模（按产品和复合年增长率划分）（2026-2033 年）
- 消耗品
- 墨水匣
- 聚合物
- 玻璃
- 硅
- 试剂
- 系统
全球微流体免疫检测市场规模（依技术及复合年增长率划分）（2026-2033 年）
- 电化学检测
- 光学检测
全球微流体免疫检测市场规模（按应用及复合年增长率划分）（2026-2033 年）
- 心臟病学
- 单一生物标记检测
- 多重生物标记检测
- 感染疾病
- 肿瘤学
- 其他用途
全球微流体免疫检测市场规模（依最终用户划分）及复合年增长率（2026-2033 年）
- 製药和生物技术公司
- 诊断检查室
- 医院
- 其他最终用户
全球微流体免疫检测市场规模（按地区划分）及复合年增长率（2026-2033 年）
- 北美洲
- 美国
- 加拿大
- 欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
- 亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
- 拉丁美洲
- 巴西
- 其他拉丁美洲地区
- 中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区
竞争资讯
- 前五大公司对比
- 主要企业的市场定位（2025 年）
- 主要市场参与者所采取的策略
- 近期市场趋势
- 公司市占率分析（2025 年）
- 主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较
主要企业简介
- Abbott Laboratories（US）
- Bio-Rad Laboratories（US）
- Becton, Dickinson and Company（US）
- Danaher Corporation（US）
- Fluidigm Corporation（US）
- GE Healthcare（US）
- Illumina Inc.（US）
- Luminex Corporation（US）
- Merck Millipore（Germany）
- PerkinElmer Inc.（US）
- Randox Laboratories Ltd.（UK）
- Roche Diagnostics（Switzerland）
- Siemens Healthineers AG（Germany）
- Thermo Fisher Scientific Inc.（US）
- Tosoh Corporation（Japan）
- Wako Pure Chemical Industries, Ltd.（Japan）
- Waters Corporation（US）
结论与建议
Global Microfluidic Immunoassay Market size was valued at USD 1.29 Billion in 2024 and is poised to grow from USD 1.39 Billion in 2025 to USD 2.54 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).
The microfluidic immunoassay market is experiencing significant growth, driven by the need for improved patient care in resource-limited settings. Point-of-care (POC) testing is becoming increasingly accessible in hospitals, clinics, and homes, fueled by demographic changes and a demand for cost-effective, high-throughput diagnostic solutions. Despite ongoing challenges with current POC devices-such as sample pre-treatment requirements and inconsistent results-there is a notable shift towards miniaturized, lab-on-a-chip (LOC) systems. These systems offer advantages like reduced reagent consumption and rapid, accurate results. Factors contributing to market expansion include increased research in microfluidic technology, substantial venture capital investments in LOC-based diagnostics, the urgency of rapid decision-making in emergency care, and the rising prevalence of chronic diseases among the aging population.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microfluidic Immunoassay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Microfluidic Immunoassay Market Segments Analysis
Global Microfluidic Immunoassay Market is segmented by Product, Technology, Application, End User and region. Based on Product, the market is segmented into Consumables, Cartridges, Polymer, Glass, Silicon, Reagents and Systems. Based on Technology, the market is segmented into Electrochemical Detection and Optical Detection. Based on Application, the market is segmented into Cardiology, Single Biomarker Detection, Multiplexed Biomarker Detection, Infectious Diseases, Oncology and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Hospital and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Microfluidic Immunoassay Market
The global microfluidic immunoassay market is poised for significant growth driven by various factors, particularly in emerging economies. Opportunities for expansion are enhanced by innovative technologies, such as paper-based microfluidics. Contributing to this growth are demographics characterized by an aging population alongside a large number of patients affected by both infectious and non-communicable diseases. Furthermore, increased funding for research and development, coupled with rising demand for high-quality healthcare services, greater disposable incomes, and advancements in healthcare infrastructure, collectively foster a favorable environment for the microfluidic immunoassay market to thrive.
Restraints in the Global Microfluidic Immunoassay Market
The Global Microfluidic Immunoassay market faces several significant challenges that can impede its growth. One of the primary issues is the selection of appropriate substrate materials essential for the fabrication of microfluidic chips. Additionally, navigating the complexities of reimbursement processes can pose difficulties for manufacturers. Scaling production to meet mass-market demands remains another critical hurdle, as does the necessity to develop affordable products that can cater to the needs of less economically developed regions. Addressing these constraints is vital for maximizing the potential of this innovative market and ensuring broad accessibility to its benefits.
Market Trends of the Global Microfluidic Immunoassay Market
The Global Microfluidic Immunoassay market is experiencing a notable trend driven by the increasing adoption of lab-on-chip (LOC) technology, which consolidates complex laboratory processes onto compact devices. This shift not only enhances portability but also reduces reliance on traditional bulky equipment. Particularly, paper-based microfluidic devices are garnering significant attention, especially for point-of-care (POC) applications in developing nations, owing to their cost-effectiveness and versatility. With the ability to facilitate fluid movement through capillary action without external forces, paper substrates are being extensively explored in both academic and commercial sectors, positioning themselves as a viable solution for various medical diagnostics and enhancing accessibility in healthcare.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2025
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Case Study Analysis
Global Microfluidic Immunoassay Market Size by Product & CAGR (2026-2033)
- Market Overview
- Consumables
- Cartridges
- Polymer
- Glass
- Silicon
- Reagents
- Systems
Global Microfluidic Immunoassay Market Size by Technology & CAGR (2026-2033)
- Market Overview
- Electrochemical Detection
- Optical Detection
Global Microfluidic Immunoassay Market Size by Application & CAGR (2026-2033)
- Market Overview
- Cardiology
- Single Biomarker Detection
- Multiplexed Biomarker Detection
- Infectious Diseases
- Oncology
- Other Applications
Global Microfluidic Immunoassay Market Size by End User & CAGR (2026-2033)
- Market Overview
- Pharmaceutical & Biotechnology Companies
- Diagnostic Laboratories
- Hospital
- Other End Users
Global Microfluidic Immunoassay Market Size & CAGR (2026-2033)
- North America (Product, Technology, Application, End User)
- US
- Canada
- Europe (Product, Technology, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product, Technology, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product, Technology, Application, End User)
- Brazil
- Rest of Latin America
- Middle East & Africa (Product, Technology, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fluidigm Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Illumina Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Luminex Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck Millipore (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Randox Laboratories Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tosoh Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Wako Pure Chemical Industries, Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Waters Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
免疫检测市场规模、份额和成长分析（按产品、技术、检体、应用、最终用户和地区划分）—产业预测（2026-2033 年）
酵素免疫分析法市场按产品类型、技术、应用、检体类型、自动化程度、最终用户和地区划分
癌症和肿瘤生物标记检测市场规模、份额和趋势分析报告：按癌症类型、生物标记类型、最终用途、地区和细分市场预测（2025-2033 年）
多重检测免疫检测市场：按技术、产品、最终用户和应用划分 - 全球预测（2025-2032 年）按产品类型、最终用户、通量、技术和应用分類的自动化免疫检测设备市场—2025-2032年全球预测全球酵素免疫分析法市场：市场规模、份额、趋势分析（按产品、应用、样品、最终用途和地区划分）、细分市场预测（2025-2033 年）
2025年全球免疫检测市场报告2025年全球学术研发市场报告2025年全球自动免疫检测分析仪市场报告2025年酵素免疫分析法全球市场报告